Orthofix Medical Ownership
| OFIX Stock | USD 16.90 0.15 0.90% |
Shares in Circulation | First Issued 1991-03-31 | Previous Quarter 38.5 M | Current Value 38.7 M | Avarage Shares Outstanding 17.2 M | Quarterly Volatility 5.9 M |
Orthofix |
Orthofix Stock Ownership Analysis
About 87.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.29. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orthofix Medical has Price/Earnings To Growth (PEG) ratio of 0.33. The entity recorded a loss per share of 3.3. The firm had not issued any dividends in recent years. Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Orthofix Intl operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1087 people. To find out more about Orthofix Medical contact Massimo Calafiore at 214 937 2000 or learn more at https://orthofix.com.Besides selling stocks to institutional investors, Orthofix Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Orthofix Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Orthofix Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Orthofix Medical Quarterly Liabilities And Stockholders Equity |
|
Orthofix Medical Insider Trades History
About 5.0% of Orthofix Medical are currently held by insiders. Unlike Orthofix Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Orthofix Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Orthofix Medical's insider trades
Orthofix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Orthofix Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Orthofix Medical backward and forwards among themselves. Orthofix Medical's institutional investor refers to the entity that pools money to purchase Orthofix Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Soleus Capital Management, L.p. | 2024-12-31 | 686.4 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 659.5 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 625.1 K | Emerald Mutual Fund Advisers Trust | 2024-12-31 | 503.8 K | Northern Trust Corp | 2024-12-31 | 368.1 K | Awm Investment Company Inc | 2024-12-31 | 360.1 K | Charles Schwab Investment Management Inc | 2024-12-31 | 339.5 K | Jpmorgan Chase & Co | 2024-12-31 | 290.4 K | Goldman Sachs Group Inc | 2024-12-31 | 235.4 K | Rubric Capital Management Lp | 2024-12-31 | 3.7 M | Engine Capital Management Lp | 2024-12-31 | 3.5 M |
Orthofix Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthofix Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthofix Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Orthofix Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Orthofix Medical Outstanding Bonds
Orthofix Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Orthofix Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Orthofix bonds can be classified according to their maturity, which is the date when Orthofix Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Orthofix Medical Corporate Filings
F3 | 13th of March 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 12th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 27th of February 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.